Margin Math Works—If Revenue Doesn't Fall Further
Digitide delivered the profitability pivot management promised: EBITDA margin up 45 bps, PAT tripled. But revenue contracted 2% sequentially, and the full-year margin target now rides on executing 155 more basis points in H2 while defending against deeper organic decline.
₹759.6 Cr
−0.6% YoY, −2% QoQ
10.4%
+45 bps QoQ from Q1
₹8.9 Cr
+206% YoY, +204% QoQ
₹30.5 Cr
4.1% of total, +100% QoQ
The tension: profitability is real, volume is not
Digitide's Q2 result is a textbook case of management executing a deliberate trade: exit low-margin contracts, cut costs, invest in AI and international go-to-market—and accept revenue contraction in the near term. The math is working. EBITDA margin expanded 45 bps QoQ to 10.4%, and PAT more than tripled from ₹2.9 Cr in Q1 to ₹8.9 Cr, a +206% YoY jump. But the pivot comes at a cost: revenue is down 2% sequentially and flat-to-negative year-over-year. The question for H2 is not whether this margin expansion is real—it is—but whether Digitide can deliver an additional 155 bps of EBITDA expansion (to hit the full-year 200 bps target) while stabilizing the top line.
EBITDA increased to ₹79 Cr, up 2.5% QoQ
Delivered ₹79 Cr EBITDA; 10.4% margin vs 8% prior quarter = +240 bps (not 2.5%)
Supported (marginal pct off, absolute figures correct)
PAT tripled from ₹2.9 Cr (Q1) to ₹8.9 Cr (Q2)
Confirmed: ₹8.9 Cr Q2 PAT, ₹2.9 Cr Q1 PAT = 3.07× growth
Supported
Revenue down 2% sequentially; focus on quality not absolute growth
Delivered ₹759.6 Cr down 2% QoQ; CEO explicitly rejected 'revenue for revenue's sake' strategy
Supported
AI-led revenue doubled to ₹30.5 Cr; now 4.1% of total
AI revenue ₹30.5 Cr (vs ₹15 Cr Q1); ₹30.5÷₹760 = 4.0% of ₹760 Cr revenue
Supported
We will deliver 200 bps EBITDA margin expansion for FY27
Achieved 45 bps Q1→Q2; needs ~155 bps in H2 to reach 10% (target ~10% by FY27-end from 8%–8.5% base)
Overstated—only 22.5% of target delivered; H2 must nearly quadruple the pace
TCY bookings up 95% sequentially to ₹400 Cr
TCY ₹400 Cr vs ₹205 Cr Q1 = exact 95% growth; conversion timeline 10–16 weeks
Supported
What changed on this call
EBITDA margin uplift: 45 bps QoQ delivery reaffirms strategy is working. Only risk: 155 bps still to go in H2 is an aggressive pace.
Revenue trajectory downgraded: Q1–Q2 sequential decline (-2%) and flat YoY. Management explicitly deprioritizes volume; strategy is margin and mix, not scale.
AI momentum accelerating: Revenue ₹30.5 Cr (doubled QoQ), pipeline ₹170 Cr (+70% QoQ from ₹100 Cr prior). 6+ new orders in Q2 suggest real traction, not rehashing.
Partnership ecosystem live: AWS Advanced Tier achieved; Anthropic partnership commercialization underway; BOT mandate (700+ Philippines GCC mobilization). Go-to-market engines shifting from organic to co-sell.
Valuation discount persists: Stock down 75% from listing price. Management candid on investor trust erosion; focused defense on operational progress, not valuation narrative.
The bull-bear ledger
Margin expansion is real and replicable: +45 bps Q1→Q2 via headcount discipline (−7% QoQ, revenue per staff +12%), contract repricing, and portfolio mix shift.
International segment growing (₹323 Cr, 42.5% of Q2, +13.5% YoY) and tech/digital growing (₹244 Cr, 32.1%, +6.6% YoY). Mix is improving.
AI monetization is early but genuine: ₹30.5 Cr (4.1% of revenue) is small in absolute terms, but doubled QoQ and sits atop a ₹170 Cr pipeline with 6+ Q2 new orders. Insurance, banking, healthcare verticals showing use-case traction.
Cash generation improving despite revenue stall: H1 OCF ₹51 Cr (+27.5% YoY). DSO at 84 days, working capital tightening. Net cash ₹76 Cr (excl. lease liabilities).
Revenue contraction is strategic, not operational miss—but strategy carries execution risk. If portfolio cleanup drives deeper organic decline, margin gains will be offset by volume loss.
200 bps EBITDA target is aggressive. 155 bps remaining in H2 requires margin expansion pace to nearly quadruple vs. Q1→Q2 delivery. Leaves no room for slippage.
Lease liability burden (₹85 Cr H1) is structurally compressing PBT despite EBITDA strength. PBT improved only marginally Q1→Q2 (₹12 Cr to ₹14 Cr). Unwinding slow.
M&A pipeline has no concrete deals. Management selective on valuations but vague on capital redeployment timeline. Alldigi buyback (~₹48 Cr) earmarked for debt reduction, not growth investment.
Profitability remains structurally low: 1.2% NPM in Q2, 10.4% EBITDA margin. Even with 200 bps margin gain, NPM will only reach ~2% unless revenue stabilizes or volume premium pricing succeeds.
How the market is positioned
The stock has priced in deep skepticism. At ₹63.17, Digitide sits 27% below its 20-day average (₹68.22), 20% below its 50-day average (₹79.52), and 31% below its 200-day average (₹92.11). More starkly, the stock is −77.41% off its all-time high of ₹279.69 and has recovered only +8.48% from its 52-week low of ₹58.23. RSI at 32.1 suggests neutral technicals—not oversold, but not yet a bottoming signal. Volume is increasing, which can signal either capitulation or early institutional re-entry; the data does not distinguish. FII ownership has been trimming steadily: from 14.90% in Q1 FY2025 to 7.08% in Q1 FY2027 (most recent). DII ownership has also declined marginally (11.30% from 11.62% QoQ). Promoter ownership is stable at ~57.3%. The combination—deep FII exit, stable promoter, DII neutral—suggests the market views the turnaround as credible (else promoters would also trim) but remains unconvinced of near-term cash-flow recovery (else FII would not continue exiting).
The post-result reaction will be telling. If the stock pops on Q2 delivery and margin reaffirmation, it signals the market is beginning to re-rate the turnaround. If it fades or stays underwater, it signals skepticism that 155 bps of H2 EBITDA expansion is achievable or that revenue stabilization is imminent. The price action over the next 5–10 trading sessions will reveal whether management's operational progress is enough to begin restoring investor confidence.
The debate
EBITDA target execution failure (200 bps FY27)
HighOnly 45 bps delivered Q1→Q2; 155 bps needed in H2. If H2 margin expansion stalls or revenue contracts deeper, target misses and management credibility resets.
Revenue contraction accelerates beyond portfolio cleanup exit
HighSequential decline of −2% QoQ compounds if organic growth is negative. Volume loss offsets margin gains. Profitability at 1.2% NPM cannot offset significant revenue decline.
Lease liability drag persists on PBT
Medium₹85 Cr H1 lease outflows structure compress PBT despite EBITDA expansion. PBT margin will lag EBITDA by 200+ bps. Dividend and cash-to-shareholders remain constrained.
AI pipeline ₹170 Cr fails to convert to near-term revenue
MediumPipeline is promising (doubled QoQ) but still niche (4.1% of revenue). If conversion timeline extends beyond H2 FY27, growth narrative stalls and P&L remains under pressure.
M&A capital deployment delayed or value-destructive
LowNo concrete deals yet. If capital remains idle or is deployed into acquisitions at unfavorable valuations, opportunity cost mounts.
What to watch next
1 · TCY bookings revenue realization (₹400 Cr pipeline)
Conversion timeline is 10–16 weeks. If even 20–30% converts to Q3–Q4 revenue, it signals portfolio cleanup is not a permanent headwind. If it slips or converts lower, revenue stabilization becomes uncertain.
2 · H2 EBITDA margin delivery
Track H1 (45 bps delivered) vs. H2 pace. Management needs ~155 bps more to hit 200 bps FY27 target. Any miss on this will reset management credibility and valuation multiple expectations.
3 · AWS/Anthropic co-sell bookings and first-deal closure
AWS Advanced Tier status is live; Anthropic partnership is early-stage. First deal (₹10M+ U.S. payroll services) closed in Q2. Watch for Q3–Q4 pipeline momentum and whether co-sell becomes a material revenue driver or remains aspirational.
The number to track from here
Not PAT or revenue alone, but organic revenue run-rate ex portfolio cleanup. If management can stabilize organic revenue (i.e., flat or positive ex exits) while delivering the margin expansion, the turnaround is real. If organic revenue continues to contract, the margin gains are a Pyrrhic victory—profitability on a shrinking base. Watch quarterly organic growth (reported revenue less announced contract exits) and management's willingness to quantify it. The margin expansion is confirmed; the volume stabilization is still an open question.
Digitide's Q2 result is steady execution, not a step-change. The margin pivot is working, but the full-year target hinges on accelerating H2 delivery and defending revenue. The market's deep discount (77% off ATH, 27% below 20-day average) reflects investor skepticism, not a buy signal—hold until TCY bookings and H2 EBITDA color clarify the path to profitability without further volume erosion.
Informational and educational content only. Not investment advice.